KAD THERAPY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KAD THERAPY
Largest movements
- Deferred charges and accrued income +€7,796
up €7,796 (+512%), from €1,522 to €9,318
- Cash +€6,412
up €6,412 (+8.0%), from €79,815 to €86,227
mainly Net result for the year (+€19,000) and Accrued charges and deferred income (+€1,893)
- Receivables within one year +€2,208
up €2,208 (+86.8%), from €2,545 to €4,753
- Tangible fixed assets -€1,198
down €1,198 (-100%), from €1,198 to €0
- Reserves +€17,200
up €17,200 (+22.8%), from €75,600 to €92,800
- Other debts -€4,948
no longer reported in 2025 (was €4,948)
- Accrued charges and deferred income +€1,893
new in 2025: €1,893
- Tax, wage and social debts +€1,704
up €1,704 (+109%), from €1,566 to €3,270
- Gross operating margin -€15,925
down €15,925 (-34.6%), from €45,994 to €30,069
- Taxes -€3,731
down €3,731 (-32.3%), from €11,540 to €7,809
- Depreciation -€2,396
down €2,396 (-66.7%), from €3,594 to €1,198
- Other operating charges -€464
down €464 (-26.8%), from €1,734 to €1,270
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €85,080 | €100,298 | +€15,218 | +17.9% |
| Fixed assets | 21/28 | €1,198 | €0 | -€1,198 | -100% |
| Tangible fixed assets | 22/27 | €1,198 | €0 | -€1,198 | -100% |
| Furniture and vehicles | 24 | €1,198 | €0 | -€1,198 | -100% |
| Current assets | 29/58 | €83,882 | €100,298 | +€16,416 | +19.6% |
| Amounts receivable within one year | 40/41 | €2,545 | €4,753 | +€2,208 | +86.8% |
| Trade receivables | 40 | €2,545 | €4,753 | +€2,208 | +86.8% |
| Cash at bank and in hand | 54/58 | €79,815 | €86,227 | +€6,412 | +8.0% |
| Deferred charges and accrued income | 490/1 | €1,522 | €9,318 | +€7,796 | +512% |
| Total equity and liabilities | 10/49 | €85,080 | €100,298 | +€15,218 | +17.9% |
| Equity | 10/15 | €76,100 | €93,300 | +€17,200 | +22.6% |
| Contributions | 10/11 | €500 | €500 | = | 0.0% |
| Reserves | 13 | €75,600 | €92,800 | +€17,200 | +22.8% |
| Distributable reserves | 133 | €75,600 | €92,800 | +€17,200 | +22.8% |
| Amounts payable | 17/49 | €8,980 | €6,998 | -€1,982 | -22.1% |
| Amounts payable within one year | 42/48 | €8,980 | €5,105 | -€3,875 | -43.2% |
| Trade debts | 44 | €2,466 | €1,835 | -€631 | -25.6% |
| Suppliers | 440/4 | €2,466 | €1,835 | -€631 | -25.6% |
| Taxes, remuneration and social security | 45 | €1,566 | €3,270 | +€1,704 | +109% |
| Taxes | 450/3 | €1,566 | €3,270 | +€1,704 | +109% |
| Other amounts payable | 47/48 | €4,948 | - | -€4,948 | |
| Accrued charges and deferred income | 492/3 | - | €1,893 | +€1,893 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,594 | €1,198 | -€2,396 | -66.7% |
| Other operating charges | 640/8 | €1,734 | €1,270 | -€464 | -26.8% |
| Gross operating margin | 9900 | €45,994 | €30,069 | -€15,925 | -34.6% |
| Operating profit (loss) | 9901 | €40,666 | €27,601 | -€13,065 | -32.1% |
| Financial charges | 65/66B | €726 | €792 | +€66 | +9.1% |
| Recurring financial charges | 65 | €726 | €792 | +€66 | +9.1% |
| Profit (loss) for the period before taxes | 9903 | €39,940 | €26,809 | -€13,131 | -32.9% |
| Income taxes | 67/77 | €11,540 | €7,809 | -€3,731 | -32.3% |
| Profit (loss) for the period | 9904 | €28,400 | €19,000 | -€9,400 | -33.1% |
| Profit (loss) for the period to be appropriated | 9905 | €28,400 | €19,000 | -€9,400 | -33.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.